Balyasny Asset Management’s Lennar Class A LEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-41,800
Closed -$4.3M 3231
2025
Q4
$4.3M Sell
41,800
-31,800
-43% -$3.84M 0.01% 1479
2025
Q3
$9.28M Buy
73,600
+33,600
+84% +$4.17M 0.01% 1093
2025
Q2
$4.42M Sell
40,000
-50,000
-56% -$5.42M 0.01% 1348
2025
Q1
$10.3M Buy
90,000
+48,680
+118% +$6.08M 0.02% 891
2024
Q4
$5.45M Buy
+41,320
New +$6.71M 0.01% 1231
2024
Q3
Sell
-23,552
Closed -$3.42M 2969
2024
Q2
$3.42M Sell
23,552
-6,302
-21% -$959K 0.01% 1335
2024
Q1
$4.97M Sell
29,854
-15,701
-34% -$2.36M 0.01% 1227
2023
Q4
$6.57M Sell
45,555
-41,320
-48% -$4.98M 0.01% 1024
2023
Q3
$9.44M Buy
86,875
+4,235
+5% +$497K 0.02% 864
2023
Q2
$10M Buy
+82,640
New +$9.02M 0.02% 778
2021
Q3
Sell
-6,508
Closed -$626K 2202
2021
Q2
$626K Buy
+6,508
New +$629K ﹤0.01% 1472
2018
Q2
Sell
-454,520
Closed -$25.9M 1985
2018
Q1
$25.9M Buy
+454,520
New +$27.4M 0.11% 257
2016
Q2
Sell
-157,584
Closed -$7.25M 1316
2016
Q1
$7.25M Buy
+157,584
New +$6.46M 0.04% 471

Other funds holding LEN

Balyasny Asset Management's LEN Position: Q1 2026 in Review

Balyasny Asset Management sold out of Lennar Class A (LEN) in Q1 2026, closing a stake of 45,731 shares — an estimated $4.7M sold.

Balyasny Asset Management first reported a position in LEN in Q2 2013 and held it in 33 quarters. The position peaked at $145M in Q1 2018. 932 funds tracked by Wall St. Rank hold LEN as of Q1 2026.

  • Balyasny Asset Management reported no remaining Lennar Class A position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 45,731 Lennar Class A shares in Q1 2026, an estimated $4.7M.
  • Balyasny Asset Management first reported a position in Lennar Class A in Q2 2013 and held it in 33 quarters.
  • Balyasny Asset Management's Lennar Class A position peaked at $145M in Q1 2018.
  • 932 funds tracked by Wall St. Rank held Lennar Class A as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.